View on Pubmed.gov 38601755 | View on doi.org 10.3389/fonc.20...
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota.
- Haematology and Oncology Department, CUF Oncologia, Lisbon, Portugal.
- NOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa (UNL), Lisbon, Portugal.
- Medical Oncology Department, Hospital de Cascais, Cascais, Portugal.
- Breast Unit, CUF Oncologia, Lisbon, Portugal.
- Haematology and Oncology Department, CUF Oncologia, Lisbon, Portugal. Breast Unit, CUF Oncologia, Lisbon, Portugal.
- Bioinformatics Department, Centro de Medicina Laboratorial Germano de Sousa, Lisbon, Portugal.
- Breast Unit, CUF Oncologia, Lisbon, Portugal. Surgery Department, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOL-FG), Lisbon, Portugal.
- Anatomic Pathology Department, CUF Oncologia, Lisbon, Portugal.
- Institute of Anatomic Pathology, Faculdade de Medicina da Universidade de Lisboa (FMUL), Lisbon, Portugal.
- Genetics Laboratory, Centro de Medicina Laboratorial Germano de Sousa, Lisbon, Portugal.
- Clinical Pathology Department, Centro de Medicina Laboratorial Germano de Sousa, Lisbon, Portugal.
- Psychology Department, CUF Descobertas Hospital, Lisbon, Portugal.
- Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS), Rede de Investigação em Saúde (RISE), NOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa (UNL), Lisbon, Portugal.
- Unidade Universitária Lifestyle Medicine José de Mello Saúde, NOVA Medical School (NMS), Lisbon, Portugal.
- Comprehensive Health Research Centre (CHRC), NOVA Medical School, Faculdade de Ciências Médicas, Lisbon, Portugal.
Abstract
Locally advanced breast cancer poses significant challenges to the multidisciplinary team, in particular with hormone receptor (HR) positive, HER2-negative tumors that classically yield lower pathological complete responses with chemotherapy. The increasingly significant use of CDK 4/6 inhibitors (CDK4/6i) plus endocrine therapy (ET) in different breast cancer settings has led to clinical trials focusing on this strategy as a primary treatment, with promising results. The impact of the microbiota on cancer, and vice-versa, is an emerging topic in oncology. The authors report a clinical case of a postmenopausal female patient with an invasive breast carcinoma of the right breast, Luminal B-like, staged as cT4cN3M0 (IIIB). Since the lesion was considered primarily inoperable, the patient started letrozole and ribociclib. Following 6 months of systemic therapy, the clinical response was significant, and surgery with curative intent was performed. The final staging was ypT3ypN2aM0, R1, and the patient started adjuvant letrozole and radiotherapy. This case provides important insights on primary CDK4/6i plus ET in locally advanced unresectable HR+/HER2- breast cancer and its potential implications in disease management further ahead. The patient's gut microbiota was analyzed throughout the disease course and therapeutic approach, evidencing a shift in gut microbial dominance from Firmicutes to Bacteroidetes and a loss of microbial diversity following 6 months of systemic therapy. The analysis of the intratumoral microbiota from the surgical specimen revealed high microbial dissimilarity between the residual tumor and respective margins.
References
PLoS One. 2016 Jan 05;11(1):e0146509
BMC Microbiol. 2022 Feb 12;22(1):53
Front Microbiol. 2021 Feb 25;12:584332
J Clin Med. 2023 Mar 13;12(6):
Cited by 3 citations (total)
Journal Article Review
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives.
Electronic publication date November 26, 2024
Claudia Lombardo [...] Carla Agata Erika Loreto et al.
The human microbiota represents a heterogeneous microbial community composed of several commensal, symbiotic, and even pathogenic microorganisms colonizing both the...
Journal Article
Endoscopic surgery affects the gut microbiota and its metabolism in breast cancer patients.
Electronic publication date January 22, 2025
Jingtai Li [...] Guankui Du et al.
Background
Despite the advantages of endoscopic surgery in reducing trauma and enhancing recovery for breast cancer patients, its impact on gut...
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Copyright
Copyright © 2024 Vilhais, Alpuim Costa, Fontes-Sousa, Ribeiro, Martinho, Botelho de Sousa, Santos, Negreiros, Canastra, Borralho, Guia Pereira, Marçal, Germano Sousa, Chaleira, Rocha, Calhau and Faria.